Therapy of Colorectal Carcinoma with Monoclonal Antibodies (MAb17-1A) Alone and in Combination with Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF)-Reference-Cited by-同舟云学术

Therapy of Colorectal Carcinoma with Monoclonal Antibodies (MAb17-1A) Alone and in Combination with Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF)

Published:1991-01 Issue:8 Volume:30 Page:923-931
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Mellstedt H.,Früdin J.-E.,Ragnhammar P.,Masucci G.,Ljungberg A.,Hjelm A.-L.,Fagerberg J.,Lindemalm C.,Österborg A.,Wersäll P.,Christensson B.,Shetye J.,Biberfeld P.,Makower J.,Cedermark B.,Erwald R.,Nathansson J.,Magnusson I.,Rrieger Å.

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/02841869109088245

Reference25 articles.

1. Monoclonal antibodies and human tumours: Pathological and clinical aspects

2. Efficient selection of human tumor growth-inhibiting monoclonal antibodies

3. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

4. Isolation and characterization of a carcinoma-associated antigen

5. Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients;British Journal of Cancer;2010-09-28

2. G- and GM-CSF in oncology and oncological haematology;European Journal of Haematology;2009-04-24

3. Immunocytokines for Cancer Immunotherapy;Handbook of Cancer Vaccines;2004

4. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells;International Journal of Cancer;2002-09-03

5. Histamine as an adjunct to immunotherapy;Seminars in Oncology;2002-06